Literature DB >> 23297405

Small molecule inhibitors of phospholipase C from a novel high-throughput screen.

Weigang Huang1, Matthew Barrett, Nicole Hajicek, Stephanie Hicks, T Kendall Harden, John Sondek, Qisheng Zhang.   

Abstract

Phospholipase C (PLC) isozymes are important signaling molecules, but few small molecule modulators are available to pharmacologically regulate their function. With the goal of developing a general approach for identification of novel PLC inhibitors, we developed a high-throughput assay based on the fluorogenic substrate reporter WH-15. The assay is highly sensitive and reproducible: screening a chemical library of 6280 compounds identified three novel PLC inhibitors that exhibited potent activities in two separate assay formats with purified PLC isozymes in vitro. Two of the three inhibitors also inhibited G protein-coupled receptor-stimulated PLC activity in intact cell systems. These results demonstrate the power of the high-throughput assay for screening large collections of small molecules to identify novel PLC modulators. Potent and selective modulators of PLCs will ultimately be useful for dissecting the roles of PLCs in cellular processes, as well as provide lead compounds for the development of drugs to treat diseases arising from aberrant phospholipase activity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23297405      PMCID: PMC3581404          DOI: 10.1074/jbc.M112.422501

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

Review 1.  Potential treatment of cardiac hypertrophy and heart failure by inhibiting the sarcolemmal binding of phospholipase Cbeta1b.

Authors:  E A Woodcock; D R Grubb; P Iliades
Journal:  Curr Drug Targets       Date:  2010-08       Impact factor: 3.465

2.  Phospholipase C beta 1 deficiency is associated with early-onset epileptic encephalopathy.

Authors:  Manju A Kurian; Esther Meyer; Grace Vassallo; Neil V Morgan; Nandhini Prakash; Shanaz Pasha; Nebula A Hai; Salwati Shuib; Fatima Rahman; Evangeline Wassmer; J Helen Cross; Finbar J O'Callaghan; John P Osborne; Ingrid E Scheffer; Paul Gissen; Eamonn R Maher
Journal:  Brain       Date:  2010-09-09       Impact factor: 13.501

3.  U73122, an aminosteroid phospholipase C inhibitor, is a potent inhibitor of cardiac phospholipase D by a PIP2-dependent mechanism.

Authors:  Christof Burgdorf; Ulrich Schäfer; Gert Richardt; Thomas Kurz
Journal:  J Cardiovasc Pharmacol       Date:  2010-06       Impact factor: 3.105

4.  A fluorogenic, small molecule reporter for mammalian phospholipase C isozymes.

Authors:  Weigang Huang; Stephanie N Hicks; John Sondek; Qisheng Zhang
Journal:  ACS Chem Biol       Date:  2011-01-10       Impact factor: 5.100

5.  Phospholipase Cgamma1 is required for metastasis development and progression.

Authors:  Gianluca Sala; Francesco Dituri; Claudio Raimondi; Sara Previdi; Tania Maffucci; Marco Mazzoletti; Cosmo Rossi; Manuela Iezzi; Rossano Lattanzio; Mauro Piantelli; Stefano Iacobelli; Massimo Broggini; Marco Falasca
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

6.  General and versatile autoinhibition of PLC isozymes.

Authors:  Stephanie N Hicks; Mark R Jezyk; Svetlana Gershburg; Jason P Seifert; T Kendall Harden; John Sondek
Journal:  Mol Cell       Date:  2008-08-08       Impact factor: 17.970

7.  Phospholipase Cepsilon promotes intestinal tumorigenesis of Apc(Min/+) mice through augmentation of inflammation and angiogenesis.

Authors:  Mingzhen Li; Hironori Edamatsu; Riko Kitazawa; Sohei Kitazawa; Tohru Kataoka
Journal:  Carcinogenesis       Date:  2009-05-20       Impact factor: 4.944

8.  Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptor.

Authors:  Rhonda L Carter; Ingrid P Fricks; Matthew O Barrett; Lauren E Burianek; Yixing Zhou; Hyojin Ko; Arijit Das; Kenneth A Jacobson; Eduardo R Lazarowski; T Kendall Harden
Journal:  Mol Pharmacol       Date:  2009-09-16       Impact factor: 4.436

9.  Discovery of selective glucocorticoid receptor modulators by multiplexed reporter screening.

Authors:  Anthony N Gerber; Kiriko Masuno; Marc I Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

10.  A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma.

Authors:  Christian C Abnet; Neal D Freedman; Nan Hu; Zhaoming Wang; Kai Yu; Xiao-Ou Shu; Jian-Min Yuan; Wei Zheng; Sanford M Dawsey; Linda M Dong; Maxwell P Lee; Ti Ding; You-Lin Qiao; Yu-Tang Gao; Woon-Puay Koh; Yong-Bing Xiang; Ze-Zhong Tang; Jin-Hu Fan; Chaoyu Wang; William Wheeler; Mitchell H Gail; Meredith Yeager; Jeff Yuenger; Amy Hutchinson; Kevin B Jacobs; Carol A Giffen; Laurie Burdett; Joseph F Fraumeni; Margaret A Tucker; Wong-Ho Chow; Alisa M Goldstein; Stephen J Chanock; Philip R Taylor
Journal:  Nat Genet       Date:  2010-08-22       Impact factor: 38.330

View more
  12 in total

Review 1.  Structural insights into phospholipase C-β function.

Authors:  Angeline M Lyon; John J G Tesmer
Journal:  Mol Pharmacol       Date:  2013-07-23       Impact factor: 4.436

Review 2.  Chemical modulation of glycerolipid signaling and metabolic pathways.

Authors:  Sarah A Scott; Thomas P Mathews; Pavlina T Ivanova; Craig W Lindsley; H Alex Brown
Journal:  Biochim Biophys Acta       Date:  2014-01-15

Review 3.  The inositol pyrophosphate pathway in health and diseases.

Authors:  Anutosh Chakraborty
Journal:  Biol Rev Camb Philos Soc       Date:  2017-12-27

4.  PLCβ2 Promotes VEGF-Induced Vascular Permeability.

Authors:  Kathryn N Phoenix; Zhichao Yue; Lixia Yue; Chunxia G Cronin; Bruce T Liang; Luke H Hoeppner; Kevin P Claffey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-07-21       Impact factor: 10.514

5.  A High-Throughput Assay to Identify Allosteric Inhibitors of the PLC-γ Isozymes Operating at Membranes.

Authors:  Weigang Huang; Adam J Carr; Nicole Hajicek; Miri Sokolovski; Edhriz Siraliev-Perez; P Brian Hardy; Kenneth H Pearce; John Sondek; Qisheng Zhang
Journal:  Biochemistry       Date:  2020-10-07       Impact factor: 3.162

Review 6.  Phosphoinositides: tiny lipids with giant impact on cell regulation.

Authors:  Tamas Balla
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

7.  Fgd5 is a Rac1-specific Rho GEF that is selectively inhibited by aurintricarboxylic acid.

Authors:  Sally Park; Yitian Guo; Judeah Negre; Jordane Preto; Cameron C Smithers; Abul Kalam Azad; Michael Overduin; Allan G Murray; Gary Eitzen
Journal:  Small GTPases       Date:  2019-10-10

8.  Phospholipase cε, an effector of ras and rap small GTPases, is required for airway inflammatory response in a mouse model of bronchial asthma.

Authors:  Tatsuya Nagano; Hironori Edamatsu; Kazuyuki Kobayashi; Nobuyuki Takenaka; Masatsugu Yamamoto; Naoto Sasaki; Yoshihiro Nishimura; Tohru Kataoka
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

9.  Phosphoinositide-3-Kinase Is the Primary Mediator of Phosphoinositide-Dependent Inhibition in Mammalian Olfactory Receptor Neurons.

Authors:  Kirill Ukhanov; Elizabeth Corey; Barry W Ache
Journal:  Front Cell Neurosci       Date:  2016-04-11       Impact factor: 5.505

10.  Charge Shielding of PIP2 by Cations Regulates Enzyme Activity of Phospholipase C.

Authors:  Jong Bae Seo; Seung-Ryoung Jung; Weigang Huang; Qisheng Zhang; Duk-Su Koh
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.